<b>Post-COVID Biotechnological Innovations:</b><b>mRNA Platforms, Long COVID Therapies, and Pandemic Preparedness</b>
The COVID-19 pandemic accelerated breakthroughs in biotechnological innovation, spotlighting rapid vaccine development, particularly mRNA platforms. Beyond managing acute infections, novel therapeutic strategies are vital to address Long COVID's complex multi-organ sequelae. Concurrently, systemic gaps revealed by the pandemic have fostered robust frameworks for enhanced pandemic preparedness. This paper provides an in-depth analysis of these post-COVID innovations, evaluating the evolution of mRNA technology, emerging therapeutics for Long COVID, and strategic advancements in global health preparedness.<br>
Publication Details
- Journal
- Figshare
- Published
- 2025-09-29
- DOI
- https://doi.org/10.6084/m9.figshare.30229021
- Primary Topic
- Economics of Agriculture and Food Markets
- Type
- article
- Field-Weighted Citation Impact
- 0.00